Royal Bank Of Canada Atai Life Sciences N.V. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Royal Bank Of Canada holds 49,529 shares of ATAI stock, worth $85,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,529

Previous 49,724 0.39%

Holding current value

$85,685

Previous $66,000 13.64%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.16 - $1.64 $226 - $319	-195 Reduced 0.39%	49,529 $57,000
Q2 2024 Aug 14, 2024	SELL	$1.27 - $2.6 $2,540 - $5,200	-2,000 Reduced 3.87%	49,724 $66,000
Q1 2024 Nov 05, 2024	BUY	$1.5 - $2.19 $3,000 - $4,380	2,000 Added 4.02%	51,724 $101,000
Q1 2024 May 15, 2024	BUY	$1.5 - $2.19 $2,356 - $3,440	1,571 Added 3.13%	51,724 $101,000
Q4 2023 Feb 14, 2024	SELL	$1.04 - $1.55 $3,395 - $5,060	-3,265 Reduced 6.11%	50,153 $70,000
Q3 2023 Nov 14, 2023	SELL	$1.27 - $2.28 $19 - $34	-15 Reduced 0.03%	53,418 $68,000
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.19 $1,962 - $2,984	1,363 Added 2.62%	53,433 $91,000
Q1 2023 May 15, 2023	BUY	$1.17 - $2.7 $276 - $637	236 Added 0.46%	52,070 $94,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $3,479 - $5,190	1,462 Added 2.9%	51,834 $137,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $24,652 - $38,234	-7,851 Reduced 13.48%	50,372 $167,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $21,022 - $36,910	6,938 Added 13.53%	58,223 $211,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $224,775 - $369,480	48,235 Added 1581.48%	51,285 $261,000
Q4 2021 Feb 14, 2022	SELL	$6.82 - $17.8 $7,467 - $19,491	-1,095 Reduced 26.42%	3,050 $23,000
Q3 2021 Nov 15, 2021	BUY	$13.62 - $19.48 $50,394 - $72,076	3,700 Added 831.46%	4,145 $61,000
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $7,538 - $8,851	445 New	445 $8,000

Others Institutions Holding ATAI

# of Institutions

Shares Held

12.4M

Call Options Held

77.8K

Put Options Held

50.3K

View Full List

About ATAI Life Sciences N.V.

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $287M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

More about ATAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Atai Life Sciences N.V. Transaction History